Bosh sahifaOGN • NYSE
add
Organon & Co
Yopilish kursi
16,00 $
Kunlik diapazon
15,75 $ - 16,10 $
Yillik diapazon
13,87 $ - 23,10 $
Bozor kapitalizatsiyasi
4,08 mlrd USD
Oʻrtacha hajm
3,97 mln
Narx/foyda
3,14
Dividend daromadliligi
7,07%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,58 mlrd | 4,15% |
Joriy xarajat | 533,00 mln | -21,04% |
Sof foyda | 359,00 mln | 518,97% |
Sof foyda marjasi | 22,69 | 493,98% |
Har bir ulushga tushum | 0,87 | 0,00% |
EBITDA | 459,00 mln | 56,66% |
Amaldagi soliq stavkasi | -73,43% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 763,00 mln | 84,30% |
Jami aktivlari | 12,75 mlrd | 15,80% |
Jami passivlari | 12,26 mlrd | 5,67% |
Umumiy kapital | 493,00 mln | — |
Tarqatilgan aksiyalar | 257,54 mln | — |
Narxi/balansdagi bahosi | 8,38 | — |
Aktivlardan daromad | 7,83% | — |
Kapitaldan daromad | 10,81% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 359,00 mln | 518,97% |
Operatsiyalardan naqd pul | 141,00 mln | -45,98% |
Sarmoyadan naqd pul | -75,00 mln | -36,36% |
Moliyadan naqd pul | -78,00 mln | 0,00% |
Naqd pulning sof oʻzgarishi | 59,00 mln | -32,95% |
Boʻsh pul | 29,00 mln | -85,07% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Tashkil etilgan
2020
Sayt
Xodimlar soni
10 000
